Woessner’s Representative Issued Patents

PDF of Woessner Representative Issued Patents

Representative Issued Patents Drafted and/or Prosecuted by Warren D. Woessner

 Pharmaceuticals, Biologicals

 Genes and Gene Therapy

 Microoganisms/Cell Culture Technology/Stem Cells

 Monoclonal Antibodies and Diagnostic Methods

 Enzymology

 Polypeptides

 Agricultural Biotechnology

 Methods of Medical Treatment

 Drug Delivery Systems

 Medical Devices

 DNA Isolation and Synthesis

 Vaccines

Pharmaceuticals, Biologicals

 Poniard Pharmaceuticals, Inc. (U.S. Pat. No. 7,696,331): HIGH-DOSE RADIONUCLIDE COMPLEXES

 Genzyme Corp. (U.S. RE41,209E): PLATINUM COMPLEXES

 Orphan Medical, Inc. (U.S. Pat. No. 7,572,605): GAMMA-HYDROXYBUTYRATE COMPOSITIONS

 Orphan Medical, Inc. (U.S. Pat. No. 7,262,219): GAMMA-HYDROXY BUTYRATE FOR THE TREATMENT OF NARCOLEPSY

 University of California (U.S. Pat. No. 7,141,603): ANTITUMOR AGENTS

 Aesgen, Inc. (U.S. Pat. No. 6,211,169): STABLE CALCITRIOL SOLUTION FOR PACKAGING INTO VIALS

 University of Minnesota (U.S. Pat. No. 6,534,512): DIDEOXYCARBOCYCLIC NUCLEOSIDES

 University of Minnesota (U.S. Pat. No. 5,929,087): DECAHYDROQUINOLINE-BASED ANTI-CHOLINERGIC AGENTS

 Mayo Clinic (U.S. Patent No. 5,783,584): THA ANALOGS USEFUL AS CHOLINESTERASE INHIBITORS

 Research Corp. Technologies (U.S. Patent No. 5,840,859): (AMINOSTYRYL) PYRIDIUM COMPOUNDS FOR RADIOLABELLING CELL MEMBRANES

 Research Corp. Technologies (U.S. Patent No. 5,648,378): 2-IMINOCHROMENE DERIVATIVES AS INHIBITORS OF PTK

Genes and Gene Therapy

 Mayo Clinic/Hybritech, Inc. (U.S. Pat. No. 6,013,471): DNA ENCODING VARIANT HK2 POLYPEPTIDES.

 Mayo Clinic (U.S. Patent No. 5,470,737): STABLY-TRANSFORMED CELLS EXPRESSING HUMAN THIOPURINE METHYLTRANSFERASE

 Mayo Clinic (U.S. Patent No. 5,744,355): CLONING AND EXPRESSION OF HUMAN LIVER ESTROGEN TRANSFERASE

 Mayo Clinic (U.S. Patent 5,618,695): DNA ENCODING HEM-1

 University of Minnesota (U.S. Pat. No. 6,238,916): DNA ENCODING TURKEY HYPOTHALMIC VASOACTIVE INTESTINAL PEPTIDE

 University of Rochester (U.S. Patent 5,601,818): CANCER THERAPY UTILIXING MALIGNANT CELLS EXPRESSING HSV-TK

Microogranisms/Cell Culture Technology/Stem Cells

 University of Minnesota (U.S. Pat. No. 7,015,037): MULTIPOTENT STEM CELLS AND METHODS FOR ISOLATION

 University of Minnesota (U.S. Pat. No. 6,277,557): INFUSIBLE GRADE SHORT-TERM CELL STORAGE MEDIUM

 U of Minnesota (U.S. Patent No. 5,460,964): METHOD FOR CULTURING HEMATOPOIETIC CELLS

 U of Minnesota (U.S. Patent No. 5,436,151): METHOD FOR CULTURING HUMAN HEMATOPOIETIC STEM CELLS IN VITRO

 Mayo Clinic (U.S. Patent No. 5,693,511): IMMORTALIZED HUMAN FETAL OSTEOBLASTIC CELLS

Monoclonal Antibodies and Diagnostic Methods

 University of Arkansas (U.S. Pat. No. 7,601,800): COMPOSITIONS AND METHODS FOR MONITORING BREAST CANCER TREATMENT

 Research Corporation Technologies, Inc.(U. S. Pat. No. 6,106,834): USE OF ANTI-CD45 LEUKOCYTE ANTIGEN ANTIBODIES FOR IMMUNOMODULATION.

 University of Minnesota (U.S. Pat. No. 5,919,457): TXU-5/B53-APA ANTVIRAL THERAPEUTIC AGENT FOR THE TREATMENT OF AIDS.

 Mayo Clinic (U.S. Pat. No 5,827,497): CHARCOAL – RADIONUCLIDE AGENTS FOR MEASUREMENT OF GASTROINTESTINAL TRANSIT.

 Mayo Clinic (U.S. Patent No. 5,529,902): DIRECT FLUORESCENCE-CONJUGATED IMMUNOASSAY FOR PLATELET ACTIVATION

 NeoRx (U.S. Patent No. 5,545,569): METHODS TO DETERMINE TGF-BETA

 U of Minnesota (U.S. Patent No. 5,316,907): ENZYMATIC FLUOROMETRIC ASSAY FOR ADENYLATE CYCLASE

 Mayo Clinic (U.S. Patent No. 5,516,639): ANTIBODIES SPECIFIC FOR HUMAN PROSTATE GLANDULAR KALLIKREIN

 Mayo Clinic (U.S. Pat. No. 6,087,097): PCR DETECTION OF BORRELIA BURGDORFERI

Enzymology

 Iowa State University (U.S. Pat. No. 5,804,426): RECOMBINANT CYCLODEXTRAN GLUCANOTRANSFERASE MUTANTS

 Research Corporations Technologies (U.S. Patent No. 5,728,804): USE OF CYCLODEXTRINS FOR PROTEIN RENATURATION

 Iowa State (U.S. Patent No. 5,804,426): RECOMBINANT CYCLODEXTRAN GLUCANOTRANSFERASE MUTANTS

Polypeptides

 University of Missouri (U.S. Pat. No. 7,214,664): PEPTIDE PRO-DRUGS THAT RESIST P-GLYCOPROTEIN MEDIATED DRUG EFFLUX

 University of Missouri (U.S. Pat. No. 7,553,812): ACYCLOVIR-PEPTIDE ANALOGS

 Hybritech Inc. (U.S. Pat. No. 6,103,237); STABLE VARIANT HK2 POLYPEPTIDE

 Mayo Clinic (U.S. Patent No. 5,583,108): VASONATRIN PEPTIDE

 Mayo Clinic/Hybritech, Inc. (U.S. Pat. No. 6,093,796): RECOMBINANT HK2 POLYPEPTIDE

 U of Minnesota (U.S. Patent No. 5,523,286): A STROMA-DERIVED PROTEOGLYCAN CONTAINING COMPOSITION WHICH PROMOTES DIFFERENTIATION AND MAINTAINS THE SELF-RENEWAL CAPACITY OF LONG-TERM BONE MARROW CULTURE-INITIATING CELLS

 U of Minnesota (U.S. Pat. No. 5,424,221): KIT FOR DETECTION OF ISLET AMYLOID POLYPEPTIDE (IAPP)

 U of Minnesota (U.S. Pat. No. 5,019,646): POLYPEPTIDES WITH FIBRONECTIN ACTIVITY

 U of Minnesota (U.S. Pat. No. 5,158,884): IMMUNODOMINANT ACETYCHOLINE RECEPTOR PEPTIDES

 Mayo Clinic (U.S. Patent No. 5,260,308): METHOD TO INCREASE PERMEABILITY OF THE BLOOD-NERVE/BRAIN BARRIERS TO PROTEINS

Agricultural Biotechnology

 APC Company, Inc. (U.S. Pat. No. 7,182,962): IMMUNOSTIMULATOR FOR ANIMALS

 The Lauridsen Group (U.S. Pat. No. 7,258,870): POULTRY FEED SUPPLEMENT

 DEKALB Genetics Corp. (U.S. Pat. No. 6,025,545): METHODS AND COMPOSITIONS FOR THE PRODUCTION OF STABLY TRANSFORMED, FERTILE MONOCOT PLANTS

 DEKALB Genetics Corp. (U.S. Pat. No. 6,013,863): FERTILE TRANSGENIC CORN PLANTS

 DEKALB Genetics Corp. (U.S. Pat. No. 5,538,880): METHOD FOR PREPARING FERTILE TRANSGENIC CORN PLANTS

 DEKALB Genetics Corp. (U.S. Pat. No. 5,538,877): METHOD FOR PREPARING FERTILE TRANSGENIC CORN PLANTS

 DEKALB Genetics Corp. (U.S. Pat. No. 5,484,956): FERTILE TRANSGENIC ZEA MAYS PLANT COMPRISING HETEROLOGOUS DNA ENCODING BACILLUS THURINGIENSIS ENDOTOXIN

 DEKALB Genetics Corp. (U.S. Pat. No. 5,554,798): FERTILE GLYPHOSATE-RESISTANT TRANSGENIC CORN PLANTS

 University of Minnesota (U.S. Pat. Nos. 6,069,298; 6,146,861; 6,222,099): METHODS AND AN ACETYL COA CARBOXYLASE GENE

Methods of Medical Treatment

 University of Virginia (U.S. Pat. No. 7,442,681): METHOD OF INHIBITING VASCULAR PERMEABILITY

 Eisai Inc. (U.S. Pat. No. 7,709,529): IMPROVED TREATMENT OF CANCER WITH GLUTAMINE

 CUNY (U.S. Pat. No. 6,461,609: RECOMBINANT a-GAL-A; A THERAPY FOR FABRY DISEASE

 NeoRx (U.S. Pat. Nos. 5,770,609; 5,945,456; 6,197,789; 6,251,920; 6,262,079): PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMALLY PROLIFERATIVE SMOOTH MUSCLE CELLS

 NeoRx (U.S. Pat. Nos. 5,811,447; 5,733,925; 6,074,659): THERAPEUTIC INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS

 Mayo Clinic (U.S. Pat. No. 5,837,713): TREATMENT OF EOSINOPHIL-ASSOCIATED PATHOLOGIES

 University of Minnesota (U.S. Pat No. 5,780,479): USE OF OPIOID ANTAGONISTS TO TREAT IMPULSE CONTROL DISORDERS

 Mayo Clinic (U.S. Pat. No. 5,691,343): USE OF TOPICAL AZATHIOPRENE TO TREAT INFLAMMATORY BOWEL DISORDERS

 Mayo Clinic (U.S. Pat. No. 5,510,339): METHOD FOR TREATMENT OF BRONCHIAL ASTHMA BY ADMINISTRATION OF TOPICAL ANESTHETICS

 Center for Innovative Technology (U.S. Pat. No. 5,541,226): TOPICAL COMPOSITIONS FOR RE-EPITHELIALIZATION OF PERSISTENT EPITHELIAL DEFECTS

 Gleich (U.S. Pat. No. 5,498,410): METHOD FOR THE TREATMENT OF EOSINOPHIL-ASSOCIATED CONDITIONS WITH ANIONIC POLYMERS

 NeoRx (U.S. Pat. No. 5,472,985): PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMALLY PROLIFERATIVE SMOOTH MUSCLE CELLS

 U of Minnesota (U.S. Pat. No. 5,411,965): USE OF DELTA OPIOID RECEPTOR ANTAGONISTS TO TREAT COCAINE ABUSE

Drug Delivery Systems

 Iowa State University (U.S. Pat. No. 7563,451): CAPPED MESOPOROUS SILICATES

 Rutgers (U.S. Pat. No. 5,560,922): TRANSDERMAL ABSORPTION DOSAGE UNIT USING A POLYACRYLATE ADHESIVE POLYMER AND PROCESS

 U.S. Pat. No. 4,708,834: PREPARATION OF GELATIN-ENCAPSULATED CONTROLLED RELEASE COMPOSITION

 U.S. Pat. No. 5,368,581: METHOD FOR USING A PACKAGING SYSTEM WITH FOLDED APPLICATOR PADS FOR DRUG DELIVERY

Medical Devices

 U.S. Pat. No. 4,619,657: FLEXIBLE INTRAOCULAR LENS HOLDER

 U.S. Pat. No. 5,073,171: BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES

 U.S. Pat. No. 5,152,784: PROSTHETIC DEVICES COATED WITH A POLYPEPTIDE WITH TYPE IV COLLAGEN ACTIVITY

DNA Isolation and Synthesis

 U.S. Pat. No. 5,023,171: METHOD FOR GENE SPLICING BY OVERLAP EXTENSION USING PCR

 U.S. Pat. No. 5,243,039: BACILLUS MGA3 ASPARTOKINASE II GENE

Vaccines

 Endobiologics, Inc. (U.S. Pat. No. 7,014,857): ANTI-SEPSIS CONJUGATE VACCINE

 Mikrogen (U.S. Pat. No. 6,183,755): ACTIVE PROTEINS FROM B. BURGDORFERI

 Iowa State University (U.S. Pat. No. 5,419,907): PATHOGENIC PORCINE RESPIRATORY CORONAVIRUS

 University of Minnesota (U.S. Pat. No. 4,721,617): VACCINE AGAINST LYME DISEASE

 University of Minnesota (U.S. Pat. No. 5,843,462): DIPHTHERIA TOXIN EPITOPES

Leave a Reply